Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma.

Zhao X, Wang Y.

Open source

DOI
10.1155/2022/4127293
Published
2022-08-01
Container
Evid Based Complement Alternat Med
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/4127293,
  title = {Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma.},
  author = {Zhao X and  Wang Y.},
  year = {2022},
  journal = {Evid Based Complement Alternat Med},
  doi = {10.1155/2022/4127293},
  url = {https://doi.org/10.1155/2022/4127293}
}

RIS

TY  - JOUR
TI  - Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma.
AU  - Zhao X
AU  -  Wang Y.
PY  - 2022
JO  - Evid Based Complement Alternat Med
DO  - 10.1155/2022/4127293
UR  - https://doi.org/10.1155/2022/4127293
ER  - 

APA

X, Z., & Y., W. (2022). Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma.. Evid Based Complement Alternat Med. https://doi.org/10.1155/2022/4127293

Source records